Categories: News

CannaNova LLC Announces its Formation; CannaNova will Commercialize Consumer Cannabinoid Consumables Using DepoFilm™ Oral Film Technology

CannaNova Cannabinoid Film

Cannabinoid Film (CannaNova)

Greensboro, NC, July 19, 2022 (GLOBE NEWSWIRE) — CannaNova Cannabinoid Film

CannaNova LLC today announced its formation to pursue the consumer cannabinoid space, employing DepoFilm™ technology.   With DepoFilm™, CannaNova manufactures buccal consumer cannabinoid films.

CannaNova’s mission is to apply drug delivery principles and its second-generation oral film technology, DepoFilm™, to develop and market high performance cannabis consumables.

CannaNova CEO, Joseph Fuisz, commented:  “CannaNova is using DepofIlm™ technology to address the key challenges that consumer cannabinoid products face today.  These include: slow onset, low bioavailability, and inconsistent bioavailability from patient to patient.  We also believe many adult consumers prefer a non-confectionary format.”

“We believe that rapid onset is particularly advantageous to allow adult consumers to enjoy consumer cannabinoids at the desired dose.  Slow onset is fundamentally at odds with dose titration.   Too frequently, consumers take extra edibles while mistakenly confusing slow onset for having taken too small of a dose.”

“Our hemp-derived products will be sold in eight count child-resistant blister cards.”

CannaNova CSO, Madhu Hariharan, commented: “We are excited to bring our next generation film technology, DepoFilm™, to the consumer cannabinoid category.  Cannanova was formed to leverage our drug delivery expertise and patented technology for the consumer cannabinoid sector.”

“Consumers prefer our fast onset, mucoadhesive, buccal films over traditional means of consuming cannabinoids.” 

“In addition to these advantages, DepoFilm™ technology also enables us to make compelling, highly brandable film shapes, reflecting the quality of our products for adult consumers.”

CannaNova plans to launch a limited test market under its DeltaFilm™ brand.

About CannaNova LLC:  

CannaNova LLC develops, manufactures and markets cannabinoid consummables for adult consumers using patented DepoFilm™ technology.   CannaNova is a private company with its headquarters in Greensboro, NC.  www.cannanova.co

Attachment

CONTACT: jfuisz@fuisz.com


Staff

Recent Posts

Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide

Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…

2 hours ago

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…

2 hours ago

Optinose Announces 1-for-15 Reverse Stock Split

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…

2 hours ago

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage…

2 hours ago

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development…

2 hours ago

SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation

TEL AVIV, Israel, Dec. 26, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or…

2 hours ago